FX CorAL 40 (F00009214); FX CorAL 50 (F00009215)— 510(k) K242053

Substantially Equivalent

Fresenius Medical Care Renal Therapies Group, LLC

FDA 510(k) clearance K242053 for FX CorAL 40 (F00009214); FX CorAL 50 (F00009215), Substantially Equivalent on 2025-03-21. Applicant: Fresenius Medical Care Renal Therapies Group, LLC.

Clearance details

Applicant: Fresenius Medical Care Renal Therapies Group, LLC
Product code: Code KDI
Advisory panel: Gastroenterology, Urology
Date received: 2024-07-12
Decision date: 2025-03-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Waltham, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code KDI

product code KDI

Death: 352
Injury: 1,474
Malfunction: 12,534
Other: 4
Total: 14,364

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.